InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: hovacre post# 59468

Wednesday, 03/14/2018 12:21:37 PM

Wednesday, March 14, 2018 12:21:37 PM

Post# of 108192
Since the company is running Aim2Cerv as the PIII, wouldn't that serve as the confirmation trial for conditional approval? There are few options for recurrent cervical cancer. I would hope the EMA keeps this first and foremost in their minds.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News